Key takeaways. An MSO (management services organization) is a non-clinical company that handles the business side of a medical practice — billing, operations, HR, technology. It exists largely because of the corporate practice of medicine (CPOM): state laws that, in many states, bar non-physicians from owning a medical practice or directing clinical care. In CPOM states, a non-physician buyer typically acquires the MSO while licensed physicians retain the clinical entity. The rules vary by state and determine how — and whether — a deal can be structured. (Informational only — not legal advice.)
Question-based outline
- What is the corporate practice of medicine?
- What is an MSO, and what problem does it solve?
- How does the MSO structure work in a sale?
- Why does this vary so much by state?
- How does telehealth policy fit in?
Deal structure in psychiatry is governed by rules that generalist business guides routinely overlook — and getting them wrong can make a transaction not merely costly but impermissible. Two concepts sit at the center: the corporate practice of medicine and the MSO. Understanding both is essential to understanding what is actually being sold when a psychiatry practice changes hands.
The corporate practice of medicine, defined.
The corporate practice of medicine (CPOM) is a body of state law that, in many states, prohibits non-physicians and corporations from owning a medical practice or controlling clinical decisions. The principle behind it is that medical judgment should rest with licensed clinicians, not with investors or lay owners. In practice, CPOM means that in a great many states, a private-equity firm or a corporate buyer cannot simply purchase your psychiatry practice the way it might buy a retail business. The rules differ markedly from state to state — some enforce CPOM strictly, others barely at all — which is why your state of operation is one of the first facts that shapes any deal.
The MSO, and the problem it solves.
A management services organization (MSO) is a non-clinical company that provides the administrative backbone of a practice: billing and collections, human resources, technology, real estate, scheduling, and operations. Crucially, the MSO does not own the clinical practice or make clinical decisions. This separation is what makes investment possible in CPOM states. A non-physician buyer can own and grow the MSO — the business of the practice — while a licensed physician (or a physician-owned professional entity) retains ownership of the clinical practice itself. The clinical and administrative sides are then connected by a management services agreement that governs how they work together.
How the structure works in a sale.
When a practice in a CPOM state is sold to a non-physician buyer, the transaction is typically structured around this divide. The buyer acquires (or forms) the MSO and the management business; the clinical entity remains owned by physicians, often the selling clinician initially or a successor physician. What the buyer is really purchasing, then, is the economics of the management company and a long-term agreement with the clinical entity — not the medical practice outright. For a seller, this changes the texture of the deal: what you are selling, what you continue to hold, and what your ongoing role looks like all flow from this structure. It is also why the legal architecture of a psychiatry deal deserves attention as early as price does.
Why the variation matters.
Because CPOM is state law, there is no single national answer. A structure that is routine in one state may be unnecessary — or insufficient — in another. Multi-site practices operating across state lines can face several regimes at once. This is not a place for generic templates; it is a place where specialist legal counsel and sector-specific advisory experience determine whether a deal is even feasible, let alone optimal.
Where telehealth policy fits.
Telepsychiatry has reshaped the economics of behavioral health, and the regulations governing it — cross-state licensure, rules on prescribing controlled substances remotely, and reimbursement policy — directly affect how a practice can operate and grow. Because buyers price a practice partly on its growth runway, shifts in telehealth policy can expand or constrain what a practice is worth. Tracking these structural and regulatory currents is its own discipline, and it belongs in any serious assessment of a practice’s future.
None of this is a substitute for qualified legal and tax counsel on your specific situation — and that caveat is not boilerplate here; structure is genuinely state-specific and consequential. When you want to understand how these rules apply to a practice like yours, and how a deal would be shaped, that conversation is with advisors who work exclusively in psychiatry and behavioral health — the team at Olympic M&A.
This content is for informational purposes only and does not constitute legal, tax, accounting, or investment advice. Every transaction is unique; consult qualified advisors regarding your specific situation.
